Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome (Retracted article. See vol. 28, pg. 170, 2023)
Authors:
Open Access
- 1 April 2018
- journal article
- retracted article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 17 (4) , 4889-4898
Abstract
The purpose of the present study was to investigate the functional role of microRNA (miR)-19b in polycystic ovary syndrome (PCOS) and try to elucidate its underlying mechanisms. Expression of miR-19b and insulin-like growth factor 1 (IGF-1) was examined in ovarian cortexes [(from 18 women with PCOS and 10 who did not have PCOS (non-PCOS)] and KGN cells. Cell proliferation assays (cell viability and colony formation assay) were performed following overexpression or inhibition of miR-19b and IGF-1 or following insulin treatment in KGN cells. Expression levels of the cell cycle-associated protein cyclin D1 and cyclin-dependent kinase (CDK) 1 were analyzed following overexpression or inhibition of miR-19b and IGF-1. Potential miR-19b targets were identified by bioinformatics. Luciferase assay, reverse transcription-quantitative polymerase chain reaction and western blotting were performed to determine whether IGF-1 was a target of miR-19b. miR-19b expression was significantly decreased in the PCOS ovarian cortex and KGN cells and its identified target, IGF-1, was upregulated. miR-19b overexpression inhibited cell proliferation at G(2)/M phrase. Overexpression of IGF-1 promoted cell viability and colony formation ability in KGN cells. The expression of cyclin D1 and CDK1 was statistically increased by inhibition of miR-19b and overexpression of IGF-1. High concentrations of insulin decreased levels of miR-19b, stimulated KGN cell proliferation, and elevated IGF-1 levels. Inhibition of miR-19b promoted ovarian granulosa cell proliferation by targeting IGF-1 in PCOS. Insulin decreased the expression levels of miR-19b and stimulated cell proliferation. The present study suggested that overexpression of miR-19b may be a potential therapeutic approach for PCOS.Keywords
This publication has 38 references indexed in Scilit:
- Cdc2: a monopotent or pluripotent CDK?Cell Proliferation, 2011
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch SignalingCancer Research, 2010
- Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case–control studyCancer Causes & Control, 2010
- Aberration of blastocyst microRNA expression is associated with human infertilityFertility and Sterility, 2010
- Identification of MicroRNAs controlling human ovarian cell proliferation and apoptosisJournal of Cellular Physiology, 2009
- Granulosa Cell Survival and Proliferation Are Altered in Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Vascular Endothelial Growth Factor Tightly Regulates In Vivo Development of Murine Hepatocellular Carcinoma CellsHepatology, 1998
- Insulin and the Polycystic Ovary SyndromeNew England Journal of Medicine, 1996